Home
University of Bergen
Department of Clinical Medicine

News archive for Department of Clinical Medicine

Lars and Heidrun together in the lab.
What happens when tumors get nervous? (20.12.2024)
12 mill NOK was today (Dec. 20, 2024) awarded to Lars A. Akslen and Heidrun Vethe from the Research Council of Norway (FRIPRO) on the project "When breast cancer hits a nerve - neural involvement as a hallmark of tumor progression."
Two researchers in the Neuro-SysMed lab.
New project support to a range of Neuro-SysMed researchers (20.12.2024)
The Western Norway Regional Health Authorities (Helse Vest) has recently announced their project funding for 2025, and we are happy to see many Neuro-SysMed researchers in their announcement. In addition, other funding agencies have also granted support to our projects this fall.
Picture from the auditorium with many people in the audience, and the speaker being introduced on the stage.
Inspirational last CCBIO seminar of 2024 (19.12.2024)
CCBIO has a tradition of using the December meeting in its seminar series to add a different perspective and encourage our research environment to think outside of the box. This December, we had the pleasure of welcoming back Fran Balkwill, who has a unique experience in addition to her cancer research career.
Brekken as speaker on a CCBIO conference.
New biomarker identified for therapeutic intervention for reducing tumor progression (19.12.2024)
The result of years of collaboration between CCBIO PI Jim Lorens and Rolf Brekken and other colleagues in the USA, Finland, Romania and Norway, is now published in Science Signaling, with research identifying nuclear AKT3 as a new biomarker of advanced malignancy and revealing the pathway that activates AKT3 to drive epithelial-to-mesenchymal transition in pancreatic cancer.
Oddmund Nygård teaching from the stage.
Course in methods of cancer biomarker research (19.12.2024)
CCBIO recently held its signature course Methods in Cancer Biomarker Research (CCBIO905), September 25-27, 2024, at Haukeland University Hospital, providing the attending students with a full panel of standard and advanced methods with relevance for cancer biomarker research.
Collage of Tessa in Boston, standing in front of Harvard Medical School, working in the lab with a microscope, being in the library, and seeing Boston skyline.
3-month visit in Boston (19.12.2024)
This year, one of CCBIO's students got the opportunity to have a 3-month research stay in Boston, due to CCBIO's INTPART collaboration with Harvard Medical School and Boston Children's Hospital. PhD Candidate Tessa Lohr reports of a great experience, highly recommending it to other young researchers.
Collage of meeting participants and EBV-MS speakers.
The 2024 Neuro-SysMed Annual Symposium (10.12.2024)
Neuro-SysMed hosted its 2nd Annual Symposium on September 30 and October 1, 2024, at the historic Solstrand Hotel near Bergen, gathering 125 participants from various fields of neurological research. Among the distinguished guest speakers were EBV-MS Scientific Advisory Board Member Professor Gavin Giovannoni and EBV-MS Partner, Assistant Professor Kjetil Bjørnevik.
Collage of situation photos from the meeting.
2nd CCBIO-VBP Research Meeting, 2024 (02.12.2024)
This meeting at Solstrand August 28–31, 2024 was the 2nd Research Meeting in the INTPART collaboration between CCBIO and the Vascular Biology Program (VBP), Boston Children’s Hospital and Harvard Medical School, the first being the Iceland meeting in 2019. In 2019, 48 participants met in Iceland, and this year, 57 gathered at Solstrand.